Traditional Healers as Adherence Partners for Persons Living With HIV in Rural Mozambique
PLHIV
2 other identifiers
interventional
320
1 country
1
Brief Summary
The overall goal of this project is to adapt and assess the impact of a traditional healer training program/intervention on the adherence, retention, and viral load of HIV infected patients newly initiated on anti-retroviral therapy in rural Mozambique.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2015
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 10, 2015
CompletedFirst Submitted
Initial submission to the registry
March 6, 2017
CompletedFirst Posted
Study publicly available on registry
March 10, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 30, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2019
CompletedResults Posted
Study results publicly available
September 29, 2020
CompletedSeptember 29, 2020
September 1, 2020
4 years
March 6, 2017
August 10, 2020
September 8, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Retention in Care
We accessed the percentage of days where participants have medication. For example, if a participant picked up a 30 day supply of medication on August 1st but did not collect their next medication until October 1st, the patient would only be considered retained for 50% of the time.
Retention in care over 12 months
Secondary Outcomes (1)
Viral Load
12 months post-enrollment
Study Arms (2)
Standard of Care
ACTIVE COMPARATORIntervention: This group will receive only standard of care HIV treatment, including ART medications (First-line ART will consist of two nucleoside reverse-transcriptase inhibitors (NRTIs) plus a non-nucleoside reverse-transcriptase inhibitor (NNRTI)- TDF + 3TC (or FTC) + EFV as a fixed-dose combination to be taken twice a day for the rest of the patient's life), clinic-based counseling, and community searches if lost to follow up.
Traditional Healer Support Program
EXPERIMENTALThis group will receive standard of care as described above. In addition, the investigators will assess an intervention partnership with traditional healer including: community and clinic based support from a trained traditional healer. The intervention includes: (1) healer visits to the patient at home, healer support for couples counseling, healer provision of nutritional advice, and healer counsel about the importance of adherence. If anything is amiss, the healer will accompany the patient to the health facility for additional clinical services. In addition, the healer will accompany the patient on all regularly scheduled clinical visits.
Interventions
Traditional Healers will provide the "traditional healer support program" assistance, as previously described, to all newly diagnosed patients.
First-line ART will consist of two nucleoside reverse-transcriptase inhibitors (NRTIs) plus a non-nucleoside reverse-transcriptase inhibitor (NNRTI)- TDF + 3TC (or FTC) + EFV as a fixed-dose combination to be taken twice a day for the rest of the patient's life), clinic-based counseling, and community searches if lost to follow up.
Eligibility Criteria
You may qualify if:
- Patients: Individuals 18 years of age or older, HIV-infected, and newly enrolled in ART and treatment services at Namacurra Sede.
- Traditional Healers: Healers will be eligible to participate if the healer lives within 10 km of the Namacurra Sede, received previous training from FGH, is 18 years of age or older, speak Portuguese, and see at least one patient per month
You may not qualify if:
- Patients: Individuals that are currently pregnant, HIV-uninfected, and/or not yet enrolled in HIV care. Individuals who cannot give consent due to mental limitations or intoxication.
- Traditional Healers: Healers who believe they can effectively treat or cure HIV or other associated conditions will be excluded from the project.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Namacurra Sede Health Facility
Namacurra, Zambezia Province, Mozambique
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Limitations and Caveats
A pre-post intervention has inherent temporal biases. At the start of the intervention phase Mozambique shifted to a test-and-treat system; the patients in the post-intervention phase are likely substantively different from the pre-group.
Results Point of Contact
- Title
- Carolyn Audet
- Organization
- Vanderbilt University
Study Officials
- PRINCIPAL INVESTIGATOR
Carolyn Audet, PhD
Vanderbilt University
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
March 6, 2017
First Posted
March 10, 2017
Study Start
June 10, 2015
Primary Completion
May 30, 2019
Study Completion
June 30, 2019
Last Updated
September 29, 2020
Results First Posted
September 29, 2020
Record last verified: 2020-09
Data Sharing
- IPD Sharing
- Will not share